1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane multiple interactions ISO CLDN5 (Homo sapiens) 6480464 2 more ... CTD PMID:34391839 1,2-dichloroethane multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in decreased expression of CLDN5 protein] CTD PMID:30081051 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of CLDN5 protein CTD PMID:30081051 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of CLDN5 mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 3-dinitrobenzene results in decreased expression of CLDN5 mRNA CTD PMID:16142770 17alpha-ethynylestradiol decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CLDN5 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CLDN5 mRNA CTD PMID:20660070 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CLDN5 mRNA CTD PMID:15289156 and PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20064788 2,3',4,4',5-Pentachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20064788 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN5 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cldn5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CLDN5 mRNA CTD PMID:32109520 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 GDNF protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CLDN5 protein] CTD PMID:26582458 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLDN5 protein CTD PMID:26582458 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of CLDN5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of CLDN5 mRNA CTD PMID:37611474 4-tert-Octylphenol increases expression ISO Cldn5 (Rattus norvegicus) 6480464 4-tert-octylphenol results in increased expression of CLDN5 mRNA CTD PMID:17011747 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLDN5 mRNA CTD PMID:20711499 9,10-phenanthroquinone decreases expression ISO CLDN5 (Homo sapiens) 6480464 9 and 10-phenanthrenequinone results in decreased expression of CLDN5 mRNA CTD PMID:34391839 9,10-phenanthroquinone multiple interactions ISO CLDN5 (Homo sapiens) 6480464 1 more ... CTD PMID:34391839 acrolein decreases expression ISO CLDN5 (Homo sapiens) 6480464 Acrolein results in decreased expression of CLDN5 mRNA CTD PMID:20525806 acrolein multiple interactions EXP 6480464 [Ovalbumin co-treated with Acrolein] results in increased expression of CLDN5 protein CTD PMID:30608172 acrolein increases expression EXP 6480464 Acrolein results in increased expression of CLDN5 protein CTD PMID:30608172 acrolein multiple interactions ISO CLDN5 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of CLDN5 mRNA] CTD PMID:20525806 acrolein increases expression ISO CLDN5 (Homo sapiens) 6480464 Acrolein results in increased expression of CLDN5 mRNA CTD PMID:20525806 ammonium chloride affects expression ISO Cldn5 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CLDN5 mRNA CTD PMID:16483693 ampicillin multiple interactions EXP 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 aripiprazole decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Aripiprazole results in decreased expression of CLDN5 mRNA CTD PMID:17868501 arsenous acid decreases expression ISO CLDN5 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CLDN5 protein CTD PMID:28115242 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CLDN5 mRNA CTD PMID:30032600 and PMID:30225639 arsenous acid multiple interactions ISO CLDN5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] CTD PMID:28115242 benzo[a]pyrene increases expression ISO CLDN5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CLDN5 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO CLDN5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CLDN5 exon CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CLDN5 mRNA CTD PMID:19770486 more ... bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of CLDN5 protein CTD PMID:37858774 bisphenol A increases expression ISO Cldn5 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CLDN5 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CLDN5 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CLDN5 gene CTD PMID:31601247 bisphenol A decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CLDN5 mRNA CTD PMID:30816183 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLDN5 mRNA CTD PMID:25594700 and PMID:37611474 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of CLDN5 mRNA CTD PMID:30951980 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of CLDN5 mRNA CTD PMID:20711499 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CLDN5 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CLDN5 mRNA CTD PMID:37325564 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of CLDN5 mRNA CTD PMID:25620056 carboxy-PTIO multiple interactions ISO CLDN5 (Homo sapiens) 6480464 1 more ... CTD PMID:34391839 CGP 52608 multiple interactions ISO CLDN5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CLDN5 gene] CTD PMID:28238834 chlordecone decreases expression EXP 6480464 Chlordecone results in decreased expression of CLDN5 mRNA CTD PMID:33711761 chlorpyrifos affects expression ISO Cldn5 (Rattus norvegicus) 6480464 Chlorpyrifos affects the expression of CLDN5 mRNA CTD PMID:22611033 chlorpyrifos multiple interactions EXP 6480464 VEGFA protein promotes the reaction [Chlorpyrifos results in increased expression of CLDN5 protein] CTD PMID:37263558 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CLDN5 mRNA CTD PMID:34289071 and PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein] and NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]] CTD PMID:34416350 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of CLDN5 mRNA CTD PMID:18353800 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CLDN5 mRNA CTD PMID:29020013 deguelin increases expression ISO CLDN5 (Homo sapiens) 6480464 deguelin results in increased expression of CLDN5 mRNA CTD PMID:19861542 deguelin decreases expression ISO CLDN5 (Homo sapiens) 6480464 deguelin results in decreased expression of CLDN5 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO CLDN5 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dexamethasone inhibits the reaction [sodium bisulfide results in decreased expression of CLDN5 protein]] more ... CTD PMID:28741371 and PMID:32404561 dexamethasone multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 and PMID:32404561 diallyl disulfide decreases expression ISO CLDN5 (Homo sapiens) 6480464 diallyl disulfide results in decreased expression of CLDN5 mRNA and diallyl disulfide results in decreased expression of CLDN5 protein CTD PMID:20600798 diallyl trisulfide decreases expression ISO CLDN5 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of CLDN5 mRNA and diallyl trisulfide results in decreased expression of CLDN5 protein CTD PMID:24084732 diarsenic trioxide decreases expression ISO CLDN5 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CLDN5 protein CTD PMID:28115242 diarsenic trioxide multiple interactions ISO CLDN5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] CTD PMID:28115242 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CLDN5 mRNA CTD PMID:30032600 and PMID:30225639 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CLDN5 mRNA CTD PMID:15289156 diethylstilbestrol increases expression ISO Cldn5 (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of CLDN5 mRNA CTD PMID:17011747 diiodine multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of CLDN5 protein CTD PMID:23876515 dipyridamole increases expression EXP 6480464 Dipyridamole results in increased expression of CLDN5 mRNA CTD PMID:20711499 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CLDN5 mRNA CTD PMID:19277126 elemental selenium multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of CLDN5 mRNA CTD PMID:34813904 fulvestrant multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CLDN5 gene CTD PMID:31601247 furan increases expression ISO Cldn5 (Rattus norvegicus) 6480464 furan results in increased expression of CLDN5 mRNA CTD PMID:27387713 gamma-linolenic acid multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CLDN5 mRNA CTD PMID:15289156 genistein increases expression EXP 6480464 Genistein results in increased expression of CLDN5 mRNA CTD PMID:32186404 gentamycin decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CLDN5 mRNA CTD PMID:22061828 glycine decreases expression ISO CLDN5 (Homo sapiens) 6480464 Glycine results in decreased expression of CLDN5 protein CTD PMID:30605748 glyphosate decreases expression ISO CLDN5 (Homo sapiens) 6480464 Glyphosate results in decreased expression of CLDN5 protein CTD PMID:30605748 hydrogen sulfide multiple interactions EXP 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 mRNA and [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 protein CTD PMID:33068716 hydrogen sulfide multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in decreased expression of CLDN5 protein and Dexamethasone inhibits the reaction [[sodium bisulfide results in increased abundance of Hydrogen Sulfide] which results in decreased expression of CLDN5 protein] CTD PMID:28741371 hydrogen sulfide decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Hydrogen Sulfide results in decreased expression of CLDN5 mRNA and Hydrogen Sulfide results in decreased expression of CLDN5 protein CTD PMID:28741371 and PMID:32404561 hydrogen sulfide multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] and Dexamethasone inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 and PMID:32404561 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein] and NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of CLDN5 protein]] CTD PMID:34416350 lead diacetate decreases expression ISO CLDN5 (Homo sapiens) 6480464 lead acetate results in decreased expression of CLDN5 protein CTD PMID:24200059 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein CTD PMID:31730887 lead diacetate multiple interactions ISO CLDN5 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein] CTD PMID:24200059 lead(0) decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Lead results in decreased expression of CLDN5 protein CTD PMID:20970449 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein CTD PMID:31730887 lead(0) multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 [malaoxon co-treated with Lead] results in decreased expression of CLDN5 protein and [Malathion co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 linsidomine decreases expression ISO CLDN5 (Homo sapiens) 6480464 linsidomine results in decreased expression of CLDN5 protein CTD PMID:34391839 lipopolysaccharide multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLDN5 mRNA CTD PMID:35811015 loxoprofen increases expression ISO CLDN5 (Homo sapiens) 6480464 loxoprofen metabolite results in increased expression of CLDN5 protein more ... CTD PMID:34506768 LY294002 multiple interactions ISO CLDN5 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of CLDN5 mRNA] more ... CTD PMID:20525806 more ... LY294002 multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Hydrogen Sulfide results in decreased expression of CLDN5 protein] CTD PMID:28741371 LY294002 decreases expression ISO CLDN5 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CLDN5 protein CTD PMID:32404561 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IL6 protein results in decreased expression of CLDN5 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in decreased expression of CLDN5 protein] CTD PMID:26025059 malaoxon decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 malaoxon results in decreased expression of CLDN5 protein CTD PMID:20970449 malaoxon multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 [malaoxon co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 malathion multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 [Malathion co-treated with Lead] results in decreased expression of CLDN5 protein CTD PMID:20970449 malathion decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Malathion results in decreased expression of CLDN5 protein CTD PMID:20970449 medroxyprogesterone acetate increases expression ISO CLDN5 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of CLDN5 mRNA CTD PMID:20843944 methamphetamine decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Methamphetamine results in decreased expression of CLDN5 mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CLDN5 mRNA and Methamphetamine results in decreased expression of CLDN5 protein CTD PMID:35390362 and PMID:36720452 methamphetamine multiple interactions EXP 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] more ... CTD PMID:35390362 and PMID:36720452 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of CLDN5 mRNA CTD PMID:34813904 methylmercury chloride multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of CLDN5 mRNA] CTD PMID:34062221 methylmercury chloride decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 methylmercuric chloride results in decreased expression of CLDN5 mRNA CTD PMID:34062221 metronidazole multiple interactions EXP 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 microcystin-LR multiple interactions EXP 6480464 [cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein more ... CTD PMID:34416350 microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of CLDN5 protein CTD PMID:34416350 minocycline increases expression ISO Cldn5 (Rattus norvegicus) 27095946 minocycline increases expression of claudin-5 protein in left corpus callosum of rats with right carotid artery occlusion RGD N-acetyl-L-cysteine multiple interactions ISO CLDN5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [9 more ... CTD PMID:28115242 and PMID:34391839 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO CLDN5 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [9 and 10-phenanthrenequinone results in decreased expression of and affects the localization of CLDN5 protein] CTD PMID:34391839 N-methyl-4-phenylpyridinium increases expression ISO CLDN5 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLDN5 mRNA CTD PMID:24810058 neomycin multiple interactions EXP 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 nickel atom multiple interactions ISO CLDN5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CLDN5 mRNA] CTD PMID:14575637 nickel atom decreases expression ISO CLDN5 (Homo sapiens) 6480464 Nickel results in decreased expression of CLDN5 mRNA CTD PMID:25583101 nickel atom affects expression ISO CLDN5 (Homo sapiens) 6480464 Nickel affects the expression of CLDN5 mRNA CTD PMID:14575637 obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:36720452 octhilinone decreases expression EXP 6480464 2-n-octyl-4-isothiazolin-3-one results in decreased expression of CLDN5 protein CTD PMID:33806369 oxaliplatin multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLDN5 mRNA CTD PMID:25729387 ozone decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Ozone results in decreased expression of CLDN5 mRNA CTD PMID:28549673 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLDN5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CLDN5 mRNA CTD PMID:34911549 p-tert-Amylphenol increases expression ISO Cldn5 (Rattus norvegicus) 6480464 4-tert-octylphenol results in increased expression of CLDN5 mRNA CTD PMID:17011747 palmitoyl ethanolamide decreases expression ISO CLDN5 (Homo sapiens) 6480464 palmidrol results in decreased expression of CLDN5 mRNA CTD PMID:31054246 papaverine decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Papaverine results in decreased expression of CLDN5 protein CTD PMID:20728510 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CLDN5 mRNA CTD PMID:17562736 paraquat multiple interactions EXP 6480464 APOD protein affects the reaction [Paraquat results in decreased expression of CLDN5 mRNA] CTD PMID:21463325 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CLDN5 mRNA CTD PMID:21463325 perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CLDN5 mRNA CTD PMID:37995155 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CLDN5 protein CTD PMID:35066053 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 mRNA and [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 protein CTD PMID:32832901 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CLDN5 mRNA CTD PMID:19136022 picoxystrobin decreases expression ISO CLDN5 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of CLDN5 mRNA CTD PMID:33512557 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CLDN5 mRNA CTD PMID:19136022 potassium iodide decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 Potassium Iodide results in decreased expression of CLDN5 mRNA CTD PMID:32593569 progesterone increases expression ISO CLDN5 (Homo sapiens) 6480464 Progesterone results in increased expression of CLDN5 mRNA CTD PMID:17404688 progesterone multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CLDN5 mRNA CTD PMID:20660070 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 mRNA and [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 protein CTD PMID:32832901 rotenone increases expression ISO CLDN5 (Homo sapiens) 6480464 Rotenone results in increased expression of CLDN5 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CLDN5 mRNA CTD PMID:35811015 sanguinarine decreases expression ISO CLDN5 (Homo sapiens) 6480464 sanguinarine results in decreased expression of CLDN5 protein CTD PMID:19063874 selenium atom multiple interactions ISO CLDN5 (Homo sapiens) 6480464 [gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein more ... CTD PMID:16514648 silicon dioxide increases expression ISO CLDN5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CLDN5 mRNA CTD PMID:23806026 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of CLDN5 mRNA CTD PMID:21795629 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CLDN5 mRNA and sodium arsenite results in decreased expression of CLDN5 protein CTD PMID:36435854 sodium sulfide (anhydrous) multiple interactions EXP 6480464 [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 mRNA and [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of CLDN5 protein CTD PMID:33068716 testosterone affects expression EXP 6480464 Testosterone affects the expression of CLDN5 mRNA CTD PMID:20403060 thifluzamide decreases expression ISO CLDN5 (Homo sapiens) 6480464 thifluzamide results in decreased expression of CLDN5 mRNA CTD PMID:33512557 thioacetamide increases expression ISO Cldn5 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CLDN5 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of CLDN5 mRNA CTD PMID:30012374 toluene increases expression ISO Cldn5 (Rattus norvegicus) 6480464 Toluene results in increased expression of CLDN5 mRNA CTD PMID:22967744 topotecan multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CLDN5 mRNA CTD PMID:25729387 tributylstannane decreases expression ISO Cldn5 (Rattus norvegicus) 6480464 tributyltin results in decreased expression of CLDN5 protein CTD PMID:26079211 tributylstannane multiple interactions ISO Cldn5 (Rattus norvegicus) 6480464 Phycocyanin inhibits the reaction [tributyltin results in decreased expression of CLDN5 protein] CTD PMID:26079211 trichostatin A multiple interactions ISO CLDN5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CLDN5 mRNA] CTD PMID:14575637 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of CLDN5 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CLDN5 mRNA CTD PMID:35752650 triptonide increases expression EXP 6480464 triptonide results in increased expression of CLDN5 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CLDN5 mRNA CTD PMID:28973697 urethane decreases expression ISO CLDN5 (Homo sapiens) 6480464 Urethane results in decreased expression of CLDN5 mRNA CTD PMID:28818685 vancomycin multiple interactions EXP 6480464 [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA] and [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein] CTD PMID:35390362 vinclozolin affects expression ISO Cldn5 (Rattus norvegicus) 6480464 vinclozolin affects the expression of CLDN5 mRNA CTD PMID:19015723
